A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study involves study participants who have been clinically diagnosed with parkinsonian
syndrome or who are at-risk for parkinsonian syndrome, have a family history of parkinsonian
syndrome or exposure to environmental toxins potentially associated with parkinsonian
syndrome. Participants will have brain imaging to assess dopamine transporter density. The
imaging data coupled with family history and environmental exposure data may provide
important information about potential risk factors for parkinsonian syndrome.